May 09, 2025

Early Psychosis Shows Four Suicide Risk Patterns

Researchers tracked suicidal behavior in early schizophrenia and found four distinct patterns linked to depression, delayed treatment, and childhood trauma.

Conexiant

May 08, 2025

FDA Warns Physicians of Tianeptine Dangers

The FDA warns physicians about unapproved tianeptine products that are linked to severe adverse events, including dependence, toxicity, and death.

Conexiant

May 08, 2025

Naltrexone Forms Show Similar AUD Results

A randomized trial of 248 hospitalized patients with alcohol use disorder found no significant difference in drinking reduction between oral and injectable naltrexone.

Conexiant

May 07, 2025

Dr. Vinay Prasad Shakes Up FDA Leadership

The FDA has appointed Vinay Prasad as its new vaccine chief, shaking up biotech stocks and signaling potential shifts in drug approvals.

Reuters

May 06, 2025

FDA Approves TAVR Platform for Asymptomatic AS

The FDA has approved the SAPIEN 3 TAVR platform for patients with asymptomatic severe aortic stenosis based on data from the EARLY TAVR trial.

Conexiant

April 29, 2025

Surgical Management of Foreign Body Ingestion in Adults: Case Series

Diagnosis relies heavily on a careful history, including the nature of the ingested material, and complementary imaging studies.

Conexiant

April 25, 2025

Multidimensional Sleep Health Affects Heart

Sleep is not a unitary physiologic experience, the AHA states in its new scientific statement, which redefines how physicians should assess sleep’s impact on cardiometabolic health.

Conexiant

April 24, 2025

FDA Warns of Topical Finasteride Risks

The FDA has issued a safety alert on compounded topical finasteride products, citing adverse events and emphasizing the lack of regulatory approval or safety evaluation.

Conexiant

April 23, 2025

Long-Term EEG Monitoring Now Authorized in the United States

The FDA has authorized Minder, the first implantable continuous electroencephalogram monitor, offering long-term brain activity tracking for improved epilepsy management, available in the U.S.

Conexiant